Search results
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 14 hours agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 5 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 13 hours agoPfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO...
Pfizer Inc. (NYSE:PFE) Stake Boosted by Wellington Management Group LLP
ETF DAILY NEWS· 15 hours agoWellington Management Group LLP lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure ...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 5 days agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 44 minutes agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 4 hours agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed in state court in ...
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 5 hours agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 17 hours agoPfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. PFE stock was trading at $52 in early June 2022, just before ...